0001174264-16-000002.txt : 20161104 0001174264-16-000002.hdr.sgml : 20161104 20161104133032 ACCESSION NUMBER: 0001174264-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161104 DATE AS OF CHANGE: 20161104 EFFECTIVENESS DATE: 20161104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INFACARE PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001174264 IRS NUMBER: 311807488 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-273838 FILM NUMBER: 161974546 BUSINESS ADDRESS: STREET 1: 8 NESHAMINY INTERPLEX, SUITE 221 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: 267-515-5850 MAIL ADDRESS: STREET 1: 8 NESHAMINY INTERPLEX, SUITE 221 CITY: TREVOSE STATE: PA ZIP: 19053 D 1 primary_doc.xml X0707 D LIVE 0001174264 INFACARE PHARMACEUTICAL CORP 8 NESHAMINY INTERPLEX, SUITE 221 TREVOSE PA PENNSYLVANIA 19053 267-515-5850 DELAWARE None None Corporation true Dan Burns 8 Neshaminy Interplex Suite 221 Trevose PA PENNSYLVANIA 19053 Executive Officer Director Ron Goldfuss 8 Neshaminy Interplex Suite 221 Trevose PA PENNSYLVANIA 19053 Executive Officer Peter Barrett c/o InfaCare Pharmaceutical Corp 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director William Crouse c/o InfaCare Pharmaceutical Corp 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Patrick Enright c/o InfaCare Pharmaceutical Corp 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Robert Vukovich c/o InfaCare Pharmaceutical Corp 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Harold Werner c/o InfaCare Pharmaceutical Corp 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Pharmaceuticals Decline to Disclose 06b false 2016-10-26 false true Promissory Note convertible into equity of the Company. false 0 11000000 5500000 5500000 false 11 0 0 350000 true Amount to be paid to related person represents ordinary salary, excluding fringe costs. false INFACARE PHARMACEUTICAL CORP Ron Goldfuss Ron Goldfuss Chief Financial Officer 2016-11-04